8-K: Oscar Health Achieves Profitability in Q1 2024, Revenue Surges 46%

Oscar Health reported a profitable first quarter of 2024 with significant year-over-year improvements in revenue, medical loss ratio, and SG&A expense ratio.

Summary

• Oscar Health announced its financial results for the first quarter of 2024, showing a significant turnaround with a net income of $177.4 million, compared to a net loss of $39.8 million in the same quarter last year.
• Total revenue reached $2.1 billion, a 46% increase year-over-year, driven by higher membership, rate increases, and lower risk adjustment as a percentage of premiums.
• The Medical Loss Ratio (MLR) improved to 74.2%, a 210 basis point improvement year-over-year, due to disciplined pricing and cost of care initiatives.
• The SG&A Expense Ratio saw a substantial improvement of 870 basis points year-over-year, reaching 18.4%, due to lower expenses and improved efficiencies.
• Adjusted EBITDA was $219.3 million, a $168.2 million improvement compared to the same period last year.
• The company reaffirmed its full-year 2024 outlook across all metrics as provided in its financial results press release dated February 7, 2024.
• Membership totaled 1,448,408, including 1,386,980 in Individual and Small Group plans and 61,428 in Cigna + Oscar plans.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to the company's strong financial performance, significant improvements across key metrics, and reaffirmation of its full-year outlook. The achievement of profitability and substantial growth indicates a strong positive trajectory.

Positives

• The company achieved profitability in Q1 2024, a major turnaround from the previous year's loss.
• Significant revenue growth of 46% year-over-year indicates strong market traction and effective pricing strategies.
• Substantial improvements in both Medical Loss Ratio and SG&A Expense Ratio demonstrate effective cost management and operational efficiencies.
• The company's reaffirmation of its full-year 2024 outlook suggests confidence in continued positive performance.
• The increase in membership indicates growing market acceptance and demand for Oscar's health plans.

Risks

• The company's future performance is subject to risks including its ability to execute its strategy, manage growth, and retain members.
• Heightened competition in the health insurance market could impact the company's ability to maintain its growth trajectory.
• Changes in federal or state laws and regulations, particularly those related to the Affordable Care Act, could affect the company's operations and profitability.
• The company faces risks related to accurately estimating medical expenses and managing medical costs.
• There are risks associated with data security breaches and the company's ability to maintain effective internal controls.

Future Outlook

Oscar Health reaffirmed its full-year 2024 outlook across all metrics as provided in its financial results press release dated February 7, 2024, and anticipates sharing details on its long-term strategic plan at its Investor Day in June.

Management Comments

• Mark Bertolini, CEO of Oscar Health, stated that the company reported strong first quarter results, showing year-over-year improvement across all core metrics and achieving positive net income.
• The CEO also mentioned that the performance lays a solid foundation for 2024 and gives the company a clear line of sight into Total Company Adjusted EBITDA profitability this year.

Industry Context

The announcement reflects a positive trend in the health insurance sector, where companies are focusing on improving cost efficiencies and profitability. Oscar's focus on technology and member engagement aligns with the industry's move towards more personalized and data-driven healthcare solutions.

Comparison to Industry Standards

• Oscar's 46% revenue growth significantly outpaces the average growth rate of established health insurance companies, such as UnitedHealth Group and Anthem, which typically see single-digit growth.
• The improvement in MLR to 74.2% is competitive with industry leaders, although some larger players may have slightly lower MLRs due to greater scale and negotiating power.
• The 870 bps improvement in SG&A expense ratio is a significant achievement, indicating that Oscar is rapidly gaining efficiencies in its operations, which is a key focus for all health insurers.
• The positive Adjusted EBITDA of $219.3 million is a notable turnaround, as many newer health insurance companies struggle to achieve profitability in their early years. This result is a positive sign compared to companies like Bright Health, which has faced significant financial challenges.

Stakeholder Impact

• Shareholders will likely react positively to the company's strong financial performance and improved profitability.
• Employees may benefit from the company's improved financial health and growth prospects.
• Customers may see improved services and plan offerings as the company continues to grow and invest in its platform.
• Suppliers and creditors may view the company as a more stable and reliable partner due to its improved financial position.

Next Steps

• Oscar Health will host a conference call to discuss the financial results on May 7, 2024.
• The company plans to share details on its long-term strategic plan at its Investor Day in June.

Key Dates

Keywords

Oscar Health, Healthcare Technology, Health Insurance, Financial Results, Medical Loss Ratio, SG&A Expense Ratio, Adjusted EBITDA, Net Income, Revenue Growth, Membership